Autophagy and inflammatory diseases

Immunology and Cell Biology

Volumn 91, Issue 3, 2013, Pages 250-258

  Jones, Sarah A ^a,b   Mills, Kingston H G ^a,b   Harris, James ^b  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Atg; autoimmune; autophagy; cytokine; inflammation

Indexed keywords

ALPHA INTERFERON; INFLAMMASOME; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 23; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; RAPAMYCIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTATION; AUTOIMMUNE DISEASE; AUTOPHAGY; CROHN DISEASE; CYTOKINE RELEASE; DISEASE PREDISPOSITION; DRUG TARGETING; ENTERITIS; GENETIC ASSOCIATION; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN A NEPHROPATHY; INFLAMMATION; INFLAMMATORY DISEASE; LOW DRUG DOSE; NONHUMAN; OSTEOARTHRITIS; REGULATORY MECHANISM; REVIEW; RHEUMATOID ARTHRITIS; SEPSIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; AUTOPHAGY; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES;

EID: 84875229476     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2012.82     Document Type: Review

References (157)

1. Ding WX, Yin XM . recognition and activation of the misfolded protein degradation pathways through macroautophagy and the proteasome. Autophagy 2008; 4: 141-150.
2. Mizushima N. The role of the Atg1/ULK1 complex in autophagy regulation. Curr Opin Cell biol 2010; 22: 132-139.
3. Lee JW, Park S, Takahashi Y, Wang HG. The association of AMPK with ULK1 regulates autophagy. PloS one 2010; 5: e15394.
4. Filimonenko M, Isakson P, Finley KD, Anderson M, Jeong H, Melia TJ et al. The selective macroautophagic degradation of aggregated proteins requires the PI3Pbinding protein Alfy. Mol Cell 2010; 38: 265-279.
5. Simonsen A, Birkeland HC, Gillooly DJ, Mizushima N, Kuma A, Yoshimori T et al. Alfy, a novel FYVE-domain-containing protein associated with protein granules and autophagic membranes. J Cell Sci 2004; 117: 4239-4251.
6. Yang Z, Klionsky DJ. Eaten alive: a history of macroautophagy. Nat Cell Biol 2010; 12: 814-822.
7. Lum JJ, Bauer DE, Kong M, Harris MH, Li C, Lindsten T et al. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 2005; 120: 237-248.
8. Ogata M, Hino S, Saito A, Morikawa K, Kondo S, Kanemoto S et al. Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol Cell Biol 2006; 26: 9220-9231.
9. Yorimitsu T, Nair U, Yang Z, Klionsky DJ. Endoplasmic reticulum stress triggers autophagy. J Biol Chem 2006; 281: 30299-30304.
10. Newell MK, Harper ME, Fortner K, Desbarats J, Russo A, Huber SA. Does the oxidative/glycolytic ratio determine proliferation or death in immune recognition? Ann New York Acad Sci 1999; 887: 77-82.
11. Alba G, El Bekay R, Alvarez-Maqueda M, Chacon P, Vega A, Monteseirin J et al. Stimulators of AMP-activated protein kinase inhibit the respiratory burst in human neutrophils. FEBS lett 2004; 573: 219-225.
12. Pua HH, Guo J, Komatsu M, He YW. Autophagy is essential for mitochondrial clearance in mature T lymphocytes. J Immunol 2009; 182: 4046-4055.
13. Pua HH, Dzhagalov I, Chuck M, Mizushima N, He YW. A critical role for the autophagy gene Atg5 in T cell survival and proliferation. J Exp Med 2007; 204: 25-31.
14. Kroemer G, Levine B. Autophagic cell death: the story of a misnomer. Nat Rev. Mol Cell Biol 2008; 9: 1004-1010.
15. Munz C. Antigen processing via autophagy - not only for MHC class II presentation anymore? Curr Opin Immunol 2010; 22: 89-93.
16. English L, Chemali M, Duron J, Rondeau C, Laplante A, Gingras D et al. Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection. Nat Immunol 2009; 10: 480-487.
17. Crotzer VL, Blum JS. Autophagy and its role in MHC-mediated antigen presentation. J Immunol 2009; 182: 3335-3341.
18. Harris J, Hope JC, Lavelle EC. Autophagy and the immune response to TB. Transbound Emerg Dis 2009; 56: 248-254.
19. Nicola AM, Albuquerque P, Martinez LR, Dal-Rosso RA, Saylor C, De Jesus M et al. Macrophage autophagy in immunity to Cryptococcus neoformans and Candida albicans. Infect Immun 2012; 80: 3065-3076.
20. Lapaquette P, Glasser AL, Huett A, Xavier RJ, Darfeuille-Michaud A. Crohn's diseaseassociated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cell Microbiol 2010; 12: 99-113.
21. Nakagawa I, Amano A, Mizushima N, Yamamoto A, Yamaguchi H, Kamimoto T et al. Autophagy defends cells against invading group A Streptococcus. Science 2004; 306: 1037-1040.
22. Liang XH, Kleeman LK, Jiang HH, Gordon G, Goldman JE, Berry G et al. Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein. J Virol 1998; 72: 8586-8596.
23. Severa M, Giacomini E, Gafa V, Anastasiadou E, Rizzo F, Corazzari M et al. EBV stimulates TLR- and autophagy-dependent pathways and impairs maturation in plasmacytoid dendritic cells: Implications for viral immune escape. Eur J Immunol 2013; 43: 147-158.
24. Lee HK, Lund JM, Ramanathan B, Mizushima N, Iwasaki A. Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 2007; 315: 1398-1401.
25. Xu Y, Jagannath C, Liu XD, Sharafkhaneh A, Kolodziejska KE, Eissa NT. Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity 2007; 27: 135-144.
26. Tang D, Kang R, Cheh CW, Livesey KM, Liang X, Schapiro NE et al. HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene 2010; 29: 5299-5310.
27. Tang D, Kang R, Livesey KM, Cheh CW, Farkas A, Loughran P et al. Endogenous HMGB1 regulates autophagy. J Cell Biol 2010; 190: 881-892.
28. Delgado MA, Elmaoued RA, Davis AS, Kyei G, Deretic V. Toll-like receptors control autophagy. EMBO J 2008; 27: 1110-1121.
29. Gutierrez MG, Master SS, Singh SB, Taylor GA, Colombo MI, Deretic V. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 2004; 119: 753-766.
30. Harris J, Keane J. How tumour necrosis factor blockers interfere with tuberculosis immunity. Clin Exp Immunol 2010; 161: 1-9.
31. Shi CS, Kehrl JH. TRAF6 and A20 regulate lysine 63-linked ubiquitination of Beclin-to control TLR4-induced autophagy. Sci Signal 2010; 3: ra42.
32. Peral de Castro C, Jones SA, Ni Cheallaigh C, Hearnden CA, Williams L, Winter J et al. Autophagy Regulates IL-23 Secretion and Innate T Cell Responses through Effects on IL-1 Secretion. J Immunol 2012; 189: 4144-4153.
33. Harris J, De Haro SA, Master SS, Keane J, Roberts EA, Delgado M et al. T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis. Immunity 2007; 27: 505-517.
34. Ni Cheallaigh C, Keane J, Lavelle EC, Hope JC, Harris J. Autophagy in the immune response to tuberculosis: clinical perspectives. Clin Exp Immunol 2011; 164: 291-300.
35. Park HJ, Lee SJ, Kim SH, Han J, Bae J, Kim SJ et al. IL-10 inhibits the starvation induced autophagy in macrophages via class I phosphatidylinositol 3-kinase (PI3K) pathway. Mol Immunol 2011; 48: 720-727.
36. Van Grol J, Subauste C, Andrade RM, Fujinaga K, Nelson J, Subauste CS. HIV-1 inhibits autophagy in bystander macrophage/monocytic cells through Src-Akt and STAT3. PloS one 2010; 5: e11733.
37. Harris J. Autophagy and cytokines. Cytokine 2011; 56: 140-144.
38. Narita M, Young AR, Arakawa S, Samarajiwa SA, Nakashima T, Yoshida S et al. Spatial coupling of mTOR and autophagy augments secretory phenotypes. Science 2011; 332: 966-970.
39. Li YY, Ishihara S, Aziz MM, Oka A, Kusunoki R, Tada Y et al. Autophagy is required for toll-like receptor-mediated interleukin-8 production in intestinal epithelial cells. Int J Mol Med 2011; 27: 337-344.
40. Hoermannsperger G, Clavel T, Hoffmann M, Reiff C, Kelly D, Loh G et al. Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: impact on chronic inflammation. PloS one 2009; 4: e4365.
41. Kim J, Kundu M, Viollet B, Guan KL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 2011; 13: 132-141.
42. Ghislat G, Patron M, Rizzuto R, Knecht E. Withdrawal of essential amino acids increases autophagy by a pathway involving Ca2+/calmodulin-dependent kinase kinase-b (CaMKK-b). J Biol Chem 2012; 287: 38625-38636.
43. Shang L, Chen S, Du F, Li S, Zhao L, Wang X. Nutrient starvation elicits an acute autophagic response mediated by Ulk1 dephosphorylation and its subsequent dissociation from AMPK. Proc Natl Acad Sci USA 2011; 108: 4788-4793.
44. Hoyer-Hansen M, Bastholm L, Szyniarowski P, Campanella M, Szabadkai G, Farkas T et al. Control of macroautophagy by calcium, calmodulin-dependent kinase kinase-b, and Bcl-2. Mol Cell 2007; 25: 193-205.
45. Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA, Mair W et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 2011; 331: 456-461.
46. Vingtdeux V, Chandakkar P, Zhao H, d'Abramo C, Davies P, Marambaud P. Novel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloidb peptide degradation. FASEB J 2011; 25: 219-231.
47. Bai A, Yong M, Ma AG, Ma Y, Weiss CR, Guan Q et al. Novel anti-inflammatory action of 5-aminoimidazole-4-carboxamide ribonucleoside with protective effect in dextran sulfate sodium-induced acute and chronic colitis. J Pharm Exp Ther 2010; 333: 717-725.
48. Bai A, Ma AG, Yong M, Weiss CR, Ma Y, Guan Q et al. AMPK agonist downregulates innate and adaptive immune responses in TNBS-induced murine acute and relapsing colitis. Biochem Pharmacol 2010; 80: 1708-1717.
49. Nath N, Khan M, Rattan R, Mangalam A, Makkar RS, de Meester C et al. Loss of AMPK exacerbates experimental autoimmune encephalomyelitis disease severity. Biochem Biophys Res Commun 2009; 386: 16-20.
50. Park CS, Bang BR, Kwon HS, Moon KA, Kim TB, Lee KY et al. Metformin reduces airway inflammation and remodeling via activation of AMP-activated protein kinase. Biochem Pharmacol 2012; 84: 1660-1670.
51. Michalek RD, Gerriets VA, Jacobs SR, Macintyre AN, MacIver NJ, Mason EF et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J Immunol 2011; 186: 3299-3303.
52. Hammami I, Chen J, Murschel F, Bronte V, De Crescenzo G, Jolicoeur M. Immunosuppressive activity enhances central carbon metabolism and bioenergetics in myeloid-derived suppressor cells in vitro models. BMC Cell Biol 2012; 13: 18.
53. Sag D, Carling D, Stout RD, Suttles J. Adenosine 50-monophosphate- activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J Immunol 2008; 181: 8633-8641.
54. Zhao X, Zmijewski JW, Lorne E, Liu G, Park YJ, Tsuruta Y et al. Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2008; 295: L497-L504.
55. Dinarello CA. The IL-1 family and inflammatory diseases. Clin Exp Rheumatol 2002; 20(5 Suppl 27): S1-13.
56. Rider P, Carmi Y, Guttman O, Braiman A, Cohen I, Voronov E et al. IL-1a and IL-1b recruit different myeloid cells and promote different stages of sterile inflammation. J Immunol 2011; 187: 4835-4843.
57. Lalor SJ, Dungan LS, Sutton CE, Basdeo SA, Fletcher JM, Mills KH. Caspase-1- processed cytokines IL-1b and IL-18 promote IL-17 production by gd and CD4 T cells that mediate autoimmunity. J Immunol 2011; 186: 5738-5748.
58. Davis BK, Wen H, Ting JP. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol 2011; 29: 707-735.
59. Fettelschoss A, Kistowska M, LeibundGut-Landmann S, Beer HD, Johansen P, Senti G et al. Inflammasome activation and IL-1b target IL-1a for secretion as opposed to surface expression. Proc Natl Acad Sci USA 2011; 108: 18055-18060.
60. Harris KM, Fasano A, Mann DL. Cutting edge: IL-1 controls the IL-23 response induced by gliadin, the etiologic agent in celiac disease. J Immunol 2008; 181: 4457-4460.
61. Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M et al. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 1993; 261: 472-475.
62. Kim SH, Eisenstein M, Reznikov L, Fantuzzi G, Novick D, Rubinstein M et al. Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. Proc Natl Acad Sci USA 2000; 97: 1190-1195.
63. Novick D, Kim SH, Fantuzzi G, Reznikov LL, Dinarello CA, Rubinstein M. Interleukin-binding protein: a novel modulator of the Th1 cytokine response. Immunity 1999; 10: 127-136.
64. Harris J, Hartman M, Roche C, Zeng SG, O'Shea A, Sharp FA et al. Autophagy controls IL-1b secretion by targeting pro-IL-1b for degradation. J Biol Chem 2011; 286: 9587-9597.
65. Nakahira K, Haspel JA, Rathinam VA, Lee SJ, Dolinay T, Lam HC et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 2011; 12: 222-230.
66. Saitoh T, Fujita N, Jang MH, Uematsu S, Yang BG, Satoh T et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1b production. Nature 2008; 456: 264-268.
67. Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011; 469: 221-225.
68. Shi CS, Shenderov K, Huang NN, Kabat J, Abu-Asab M, Fitzgerald KA et al. Activation of autophagy by inflammatory signals limits IL-1b production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol 2012; 13: 255-263.
69. Sutton CE, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC, Mills KH. Interleukin-1 and IL-23 induce innate IL-17 production from gd T cells, amplifying Th17 responses and autoimmunity. Immunity 2009; 31: 331-341.
70. Jones SA, Sutton CE, Cua D, Mills KH. Therapeutic potential of targeting IL-17. Nat Immunol 2012; 13: 1022-1025.
71. Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003; 421: 744-748.
72. Castillo EF, Dekonenko A, Arko-Mensah J, Mandell MA, Dupont N, Jiang S et al. Autophagy protects against active tuberculosis by suppressing bacterial burden and inflammation. Proc Natl Acad Sci USA 2012; 109: E3168-E3176.
73. Amre DK, Mack D, Israel D, Morgan K, Lambrette P, Law L et al. Association between genetic variants in the IL-23R gene and early-onset Crohn's disease: results from a case-control and family-based study among Canadian children. Am J Gastroenterol 2008; 103: 615-620.
74. Hayatbakhsh MM, Zahedi MJ, Shafiepour M, Nikpoor AR, Mohammadi M. IL-23 Receptor Gene rs7517847 and rs1004819 SNPs in Ulcerative Colitis. Iran J Immunol 2012; 9: 128-135.
75. Cargill M, Schrodi SJ, Chang M, Garcia VE, Brandon R, Callis KP et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 2007; 80: 273-290.
76. Song GG, Bae SC, Choi SJ, Ji JD, Lee YH. Associations between interleukin-23 receptor polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis. Mol Biol Rep 2012; 39: 10655-10663.
77. Lee YH, Choi SJ, Ji JD, Song GG. Associations between interleukin-23R polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis. Inflamm Res 2012; 61: 143-149.
78. Sherlock JP, Joyce-Shaikh B, Turner SP, Chao CC, Sathe M, Grein J et al. IL-23 induces spondyloarthropathy by acting on ROR-gammat+ CD3+CD4-CD8- entheseal resident T cells. Nat Med 2012; 18: 1069-1076.
79. Huang X, Hua J, Shen N, Chen S. Dysregulated expression of interleukin-23 and interleukin-12 subunits in systemic lupus erythematosus patients. Mod Rheumatol 2007; 17: 220-223.
80. Wong CK, Lit LC, Tam LS, Li EK, Wong PT, Lam CW. Hyperproduction of IL-23 and IL-in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin Immunol 2008; 127: 385-393.
81. Kyttaris VC, Zhang Z, Kuchroo VK, Oukka M, Tsokos GC. Cutting edge: IL-23 receptor deficiency prevents the development of lupus nephritis in C57BL/6-lpr/lpr mice. J Immunol 2010; 184: 4605-4609.
82. Massey DC, Bredin F, Parkes M. Use of sirolimus (rapamycin) to treat refractory Crohn's disease. Gut 2008; 57: 1294-1296.
83. Laragione T, Gulko PS. mTOR regulates the invasive properties of synovial fibroblasts in rheumatoid arthritis. Mol Med 2010; 16: 352-358.
84. Cejka D, Hayer S, Niederreiter B, Sieghart W, Fuereder T, Zwerina J et al. Mammalian target of rapamycin signaling is crucial for joint destruction in experimental arthritis and is activated in osteoclasts from patients with rheumatoid arthritis. Arthritis Rheum 2010; 62: 2294-2302.
85. Kneissel M, Luong-Nguyen NH, Baptist M, Cortesi R, Zumstein-Mecker S, Kossida S et al. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts. Bone 2004; 35: 1144-1156.
86. Fernandez D, Perl A. mTOR signaling: a central pathway to pathogenesis in systemic lupus erythematosus? Discov Med 2010; 9: 173-178.
87. Bhonde MR, Gupte RD, Dadarkar SD, Jadhav MG, Tannu AA, Bhatt P et al. A novel mTOR inhibitor is efficacious in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol 2008; 295: G1237-G1245.
88. Luciani A, Villella VR, Esposito S, Brunetti-Pierri N, Medina D, Settembre C et al. Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition. Nat Cell Biol 2010; 12: 863-875.
89. Razani B, Feng C, Coleman T, Emanuel R, Wen H, Hwang S et al. Autophagy links inflammasomes to atherosclerotic progression. Cell Metab 2012; 15: 534-544.
90. Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010; 464: 1357-1361.
91. Oka T, Hikoso S, Yamaguchi O, Taneike M, Takeda T, Tamai T et al. Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature 2012; 485: 251-255.
92. Anderson CA, Boucher G, Lees CW, Franke A, D'Amato M, Taylor KD et al. Metaanalysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 2011; 43: 246-252.
93. Brinar M, Vermeire S, Cleynen I, Lemmens B, Sagaert X, Henckaerts L et al. Genetic variants in autophagy-related genes and granuloma formation in a cohort of surgically treated Crohn's disease patients. J Crohns Colitis 2012; 6: 43-50.
94. Craddock N, Hurles ME, Cardin N, Pearson RD, Plagnol V, Robson S et al. Genomewide association study of CNVs in 16000 cases of eight common diseases and 3,000 shared controls. Nature 2010; 464: 713-720.
95. Henckaerts L, Cleynen I, Brinar M, John JM, Van Steen K, Rutgeerts P et al. Genetic variation in the autophagy gene ULK1 and risk of Crohn's disease. Inflamm Bowel Dis 2011; 17: 1392-1397.
96. MacMicking JD, Taylor GA, McKinney JD. Immune control of tuberculosis by IFN-gamma-inducible LRG-47. Science 2003; 302: 654-659.
97. Singh SB, Davis AS, Taylor GA, Deretic V. Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 2006; 313: 1438-1441.
98. Singh SB, Ornatowski W, Vergne I, Naylor J, Delgado M, Roberts E et al. Human IRGM regulates autophagy and cell-autonomous immunity functions through mitochondria. Nat Cell Biol 2010; 12: 1154-1165.
99. Hampe J, Franke A, Rosenstiel P, Till A, Teuber M, Huse K et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 2007; 39: 207-211.
100. Rioux JD, Xavier RJ, Taylor KD, Silverberg MS, Goyette P, Huett A et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 2007; 39: 596-604.
101. Cadwell K, Liu JY, Brown SL, Miyoshi H, Loh J, Lennerz JK et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 2008; 456: 259-263.
102. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012; 491: 119-124.
103. Nell S, Suerbaum S, Josenhans C. The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nat Rev Microbiol 2010; 8: 564-577.
104. Lapaquette P, Bringer MA, Darfeuille-Michaud A. Defects in autophagy favour adherent-invasive Escherichia coli persistence within macrophages leading to increased pro-inflammatory response. Cell Microbiol 2012; 14: 791-807.
105. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603.
106. Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001; 357: 1925-1928.
107. Travassos LH, Carneiro LA, Ramjeet M, Hussey S, Kim YG, Magalhaes JG et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol 2010; 11: 55-62.
108. Homer CR, Richmond AL, Rebert NA, Achkar JP, McDonald C. ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn's disease pathogenesis. Gastroenterology 2010; 139: 1630-1641.
109. Ferwerda G, Kramer M, de Jong D, Piccini A, Joosten LA, Devesaginer I et al. Engagement of NOD2 has a dual effect on proIL-1b mRNA transcription and secretion of bioactive IL-1b. Eur J Immunol 2008; 38: 184-191.
110. Plantinga TS, Crisan TO, Oosting M, van de Veerdonk FL, de Jong DJ, Philpott DJ et al. Crohn's disease-associated ATG16L1 polymorphism modulates pro-inflammatory cytokine responses selectively upon activation of NOD2. Gut 2011; 60: 1229-1235.
111. Strisciuglio C, Duijvestein M, Verhaar AP, Vos AC, den Brink GR, Hommes DW et al. Impaired autophagy leads to abnormal dendritic cell-epithelial cell interactions. J Crohns Colitis 2012; S1873-9946: 00371-00376.
112. Cooney R, Baker J, Brain O, Danis B, Pichulik T, Allan P et al. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med 2010; 16: 90-97.
113. Grakoui A, Bromley SK, Sumen C, Davis MM, Shaw AS, Allen PM et al. The immunological synapse: a molecular machine controlling T cell activation. Science 1999; 285: 221-227.
114. Wildenberg ME, Vos AC, Wolfkamp SC, Duijvestein M, Verhaar AP, Te Velde AA et al. Autophagy attenuates the adaptive immune response by destabilizing the immunologic synapse. Gastroenterology 2012; 142: 1493-1503.
115. Zhou XJ, Lu XL, Lv JC, Yang HZ, Qin LX, Zhao MH et al. Genetic association of PRDM1-ATG5 intergenic region and autophagy with systemic lupus erythematosus in a Chinese population. Ann Rheum Dis 2011; 70: 1330-1337.
116. Ramos PS, Criswell LA, Moser KL, Comeau ME, Williams AH, Pajewski NM et al. A comprehensive analysis of shared loci between systemic lupus erythematosus (SLE) and sixteen autoimmune diseases reveals limited genetic overlap. PLoS Genet 2011; 142: 1493-1503.
117. Lin YC, Liang SJ, Liu YH, Hsu WH, Shih CM, Sung FC et al. Tuberculosis as a risk factor for systemic lupus erythematosus: results of a nationwide study in Taiwan. Rheumatol Int 2012; 32: 1669-1673.
118. Park SJ, Kim JH, Ha TS, Shin JI. The role of interleukin-23/interleukin- 17 axis in the development of systemic lupus erythematosus among patients with tuberculosis: Comment on: Lin YC, Liang SJ, Liu YH et al.: Tuberculosis as a risk factor for systemic lupus erythematosus: results of a nationwide study in Taiwan. Rheumatol Int 2013; 33: 271-272.
119. Han JW, Zheng HF, Cui Y, Sun LD, Ye DQ, Hu Z et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet 2009; 41: 1234-1237.
120. Harley JB, Alarcon-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP, Moser KL et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008; 40: 204-210.
121. Zang L, Xu Q, Ye Y, Li X, Liu Y, Tashiro S et al. Autophagy enhanced phagocytosis of apoptotic cells by oridonin-treated human histocytic lymphoma U937 cells. Arch Biochem Biophys 2012; 518: 31-41.
122. Ronnblom L, Alm GV, Eloranta ML. The type I interferon system in the development of lupus. Semin Immunol 2011; 23: 113-121.
123. Jia W, Pua HH, Li QJ, He YW. Autophagy regulates endoplasmic reticulum homeostasis and calcium mobilization in T lymphocytes. J Immunol 2011; 186: 1564-1574.
124. Jia W, He YW. Temporal regulation of intracellular organelle homeostasis in T lymphocytes by autophagy. J Immunol 2011; 186: 5313-5322.
125. Alessandri C, Barbati C, Vacirca D, Piscopo P, Confaloni A, Sanchez M et al. T lymphocytes from patients with systemic lupus erythematosus are resistant to induction of autophagy. FASEB J 2012; 26: 4722-4732.
126. Gaipl US, Kuhn A, Sheriff A, Munoz LE, Franz S, Voll RE et al. Clearance of apoptotic cells in human SLE. Curr Dir Autoimmun 2006; 9: 173-187.
127. Remijsen Q, Vanden Berghe T, Wirawan E, Asselbergh B, Parthoens E, De Rycke R et al. Neutrophil extracellular trap cell death requires both autophagy and superoxide generation. Cell Res 2011; 21: 290-304.
128. Mitroulis I, Kambas K, Chrysanthopoulou A, Skendros P, Apostolidou E, Kourtzelis I et al. Neutrophil extracellular trap formation is associated with IL-1b and autophagyrelated signaling in gout. PloS one 2011; 6: e29318.
129. Leffler J, Martin M, Gullstrand B, Tyden H, Lood C, Truedsson L et al. Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease. J Immunol 2012; 188: 3522-3531.
130. Garcia-Romo GS, Caielli S, Vega B, Connolly J, Allantaz F, Xu Z et al. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci. Transl Med 2011; 3: 73ra20.
131. Watanabe K, Ichinose S, Hayashizaki K, Tsubata T. Induction of autophagy by B cell antigen receptor stimulation and its inhibition by costimulation. Biochem Biophys Res Commun 2008; 374: 274-281.
132. Chaturvedi A, Dorward D, Pierce SK. The B cell receptor governs the subcellular location of Toll-like receptor 9 leading to hyperresponses to DNA-containing antigens. Immunity 2008; 28: 799-809.
133. Lui SL, Yung S, Tsang R, Zhang F, Chan KW, Tam S et al. Rapamycin prevents the development of nephritis in lupus-prone NZB/W F1 mice. Lupus 2008; 17: 305-313.
134. Ramos-Barron A, Pinera-Haces C, Gomez-Alamillo C, Santiuste-Torcida I, Ruiz JC, Buelta-Carrillo L et al. Prevention of murine lupus disease in (NZBxNZW)F1 mice by sirolimus treatment. Lupus 2007; 16: 775-781.
135. Lui SL, Tsang R, Chan KW, Zhang F, Tam S, Yung S et al. Rapamycin attenuates the severity of established nephritis in lupus-prone NZB/W F1 mice. Nephrol Dial Transplant 2008; 23: 2768-2776.
136. Cruzado JM, Poveda R, Ibernon M, Diaz M, Fulladosa X, Carrera M et al. Low-dose sirolimus combined with angiotensin-converting enzyme inhibitor and statin stabilizes renal function and reduces glomerular proliferation in poor prognosis IgA nephropathy. Nephrol Dial Transplant 2011; 26: 3596-3602.
137. Connor AM, Mahomed N, Gandhi R, Keystone EC, Berger SA. TNFa modulates protein degradation pathways in rheumatoid arthritis synovial fibroblasts. Arthritis Res Ther 2012; 14: R62.
138. Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S et al. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med 2000; 191: 275-286.
139. Lin NY, Beyer C, Giessl A, Kireva T, Scholtysek C, Uderhardt S et al. Autophagy regulates TNFa-mediated joint destruction in experimental arthritis. Ann Rheum Dis (e-pub ahead of print 12 September 2012; doi:10.1136/annrheumdis- 2012- 201671).
140. Roy A, Kolattukudy PE. Monocyte chemotactic protein-induced protein (MCPIP) promotes inflammatory angiogenesis via sequential induction of oxidative stress, endoplasmic reticulum stress and autophagy. Cell Signal 2012; 24: 2123-2131.
141. Wang K, Niu J, Kim H, Kolattukudy PE. Osteoclast precursor differentiation by MCPIP via oxidative stress, endoplasmic reticulum stress, and autophagy. J Mol Biol 2011; 3: 360-368.
142. Bruyn GA, Tate G, Caeiro F, Maldonado-Cocco J, Westhovens R, Tannenbaum H et al. Everolimus in patients with rheumatoid arthritis receiving concomitant methotrexate: a 3-month, double-blind, randomised, placebo-controlled, parallel-group, proof-ofconcept study. Ann Rheum Dis 2008; 67: 1090-1095.
143. Carames B, Taniguchi N, Otsuki S, Blanco FJ, Lotz M. Autophagy is a protective mechanism in normal cartilage, and its aging-related loss is linked with cell death and osteoarthritis. Arthritis Rheum 2010; 62: 791-801.
144. Carames B, Hasegawa A, Taniguchi N, Miyaki S, Blanco FJ, Lotz M. Autophagy activation by rapamycin reduces severity of experimental osteoarthritis. Ann Rheum Dis 2012; 71: 575-581.
145. Sasaki H, Takayama K, Matsushita T, Ishida K, Kubo S, Matsumoto T et al. Autophagy modulates osteoarthritis-related gene expression in human chondrocytes. Arthritis Rheum 2012; 64: 1920-1928.
146. Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000; 43: 155-163.
147. Makrygiannakis D, af Klint E, Lundberg IE, Lofberg R, Ulfgren AK, Klareskog L et al. Citrullination is an inflammation-dependent process. Ann Rheum Dis 2006; 65: 1219-1222.
148. Ireland JM, Unanue ER. Autophagy in antigen-presenting cells results in presentation of citrullinated peptides to CD4 T cells. J Exp Med 2011; 208: 2625-2632.
149. Watanabe E, Muenzer JT, Hawkins WG, Davis CG, Dixon DJ, McDunn JE et al. Sepsis induces extensive autophagic vacuolization in hepatocytes: a clinical and laboratory-based study. Lab Invest 2009; 89: 549-561.
150. Lo S, Yuan SS, Hsu C, Cheng YJ, Chang YF, Hsueh HW et al. Lc3 transgene Improves Survival and Attenuates Lung Injury Through Increasing Autophagosomal Clearance in Septic Mice. Ann Surg 2013; 257: 352-363.
151. Carchman EH, Rao J, Loughran PA, Rosengart MR, Zuckerbraun BS. Heme oxygenase-1-mediated autophagy protects against hepatocyte cell death and hepatic injury from infection/sepsis in mice. Hepatology 2011; 53: 2053-2062.
152. Hsieh CH, Pai PY, Hsueh HW, Yuan SS, Hsieh YC. Complete induction of autophagy is essential for cardioprotection in sepsis. Ann Surg 2011; 253: 1190-1200.
153. Fujishima Y, Nishiumi S, Masuda A, Inoue J, Nguyen NM, Irino Y et al. Autophagy in the intestinal epithelium reduces endotoxin-induced inflammatory responses by inhibiting NF-kappaB activation. Arch Biochem Biophys 2011; 506: 223-235.
154. Krakauer T, Buckley M, Issaq HJ, Fox SD. Rapamycin protects mice from staphylococcal enterotoxin B-induced toxic shock and blocks cytokine release in vitro and in vivo. Antimicrob Agents Chemother 2010; 54: 1125-1131.
155. Wu YT, Tan HL, Shui G, Bauvy C, Huang Q, Wenk MR et al. Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase. J Biol Chem 2010; 285: 10850-10861.
156. Lin YC, Kuo HC, Wang JS, Lin WW. Regulation of inflammatory response by 3- methyladenine involves the coordinative actions on akt and glycogen synthase kinase 3b rather than autophagy. J Immunol 2012; 189: 4154-4164.
157. Pelegrin P, Barroso-Gutierrez C, Surprenant A. P2-7 receptor differentially couples to distinct release pathways for IL-1b in mouse macrophage. J Immunol 2008; 180: 7147-7157.